Headlands Technologies LLC Increases Stake in Stericycle, Inc. (NASDAQ:SRCL)

Headlands Technologies LLC boosted its position in Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 1,288.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,580 shares of the business services provider's stock after purchasing an additional 10,746 shares during the quarter. Headlands Technologies LLC's holdings in Stericycle were worth $673,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SRCL. Pentwater Capital Management LP purchased a new position in shares of Stericycle in the second quarter worth about $83,010,000. Capital Research Global Investors grew its position in shares of Stericycle by 13.4% in the fourth quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider's stock valued at $296,762,000 after purchasing an additional 705,586 shares in the last quarter. Sei Investments Co. increased its holdings in shares of Stericycle by 35.5% in the fourth quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider's stock valued at $52,601,000 after purchasing an additional 277,896 shares during the last quarter. Earnest Partners LLC lifted its position in Stericycle by 12.4% during the first quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider's stock worth $129,766,000 after buying an additional 271,025 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Stericycle by 10.8% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider's stock worth $97,720,000 after buying an additional 192,045 shares during the last quarter. Hedge funds and other institutional investors own 98.82% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on SRCL shares. StockNews.com initiated coverage on shares of Stericycle in a research report on Monday. They set a "hold" rating on the stock. Truist Financial increased their price target on shares of Stericycle from $50.00 to $62.00 and gave the company a "hold" rating in a research note on Tuesday, June 4th. Keefe, Bruyette & Woods lifted their price target on shares of Stericycle from $135.00 to $142.00 and gave the company an "outperform" rating in a research report on Tuesday, June 4th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $62.00 price objective (down from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Stericycle currently has an average rating of "Hold" and an average target price of $74.00.

Stericycle Trading Up 0.0 %

NASDAQ:SRCL traded up $0.03 during trading hours on Thursday, reaching $61.70. 1,487,329 shares of the stock were exchanged, compared to its average volume of 1,093,578. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $61.77. The business has a 50-day moving average of $58.86 and a two-hundred day moving average of $54.42. The company has a market capitalization of $5.73 billion, a price-to-earnings ratio of -280.45, a PEG ratio of 3.36 and a beta of 1.11. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL - Get Free Report) last posted its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.04. The firm had revenue of $661.60 million for the quarter, compared to analyst estimates of $672.07 million. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. On average, equities analysts predict that Stericycle, Inc. will post 2.29 EPS for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.